坦索罗辛治疗慢性盆底痛综合征探究.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
坦索罗辛治疗慢性盆底痛综合征探究

坦索罗辛治疗慢性盆底痛综合征探究【摘要】目的:探讨坦索罗辛治疗慢性盆底痛综合征(CPPS)的有效性及安全性。方法:随机双盲对照研究,50例患者随机分为坦索罗辛组22例(0.2 mg每晚1次),安慰剂对照组28例。分别在治疗开始、2周、4周、12周,治疗结束4周、8周、12周观察患者CPSI评分。结果:50例患者完成研究,治疗12周后,坦索罗辛组CPSI评分较对照组有显著的下降(分别是3.5,9.8,P0.01);疼痛评分较对照组有显著改善(分别是1.7,6.0,P0.01);总有效率显著高于对照组(分别是78.2%,25.1%)。在治疗结束后12周,坦索罗辛组的CPSI评分较治疗结束时有所升高,而对照组没有显著的变化(与治疗前比较CPSI总分下降分别是4.4,1.7)。结论:坦索罗辛治疗CPPS是安全、有效的,可以显著的改善患者的疼痛症状,但远期疗效不理想。 【关键词】坦索罗辛;慢性盆底痛综合征;疗效 文章编号:1009-5519(2007)17-2545-03 中图分类号:R6 文献标识码:A Tamsulosin in chronic pelvic pain syndrome:A prospective study XIAO Wei-zhong,WANG Hong,LU Wei,et al. (Department of Urology,The Central Hospital of Fuling,Chongqing 408000,China) 【Abstract】Objective:To investigate the efficacy and safety of tamsulosin in the treatment of chronic pelvic pain syndrome(CPPS).Methods:With a prospctive,randomized,double-blind,placebo-controlled study,50 patients with CPPS,who did not receive other alpha-blocker previously,were enrolled in this study,and divided into two groups in random.22 cases in the treatment group(tamsulosin group) were treated with tamsulosin 0.2 mg once every night,while 28 cases in the control group only with placebo.The score of chronic prostatitis symptom index(CPSI) of the patients in both groups was observed at the beginning of treatment and 2,4 and 12 week after treatment as well as 4,8 and 12 weeks after the end of treatment respectively.Results:After 12 weeks of treatment,the tamsulosin group had a statistically significant decrease in total CPSI score compared with the control group (3.5 and 9.8 respectively,P0.01),especially in the pain score(1.7 and 6.0 respectively,P0.01).The total effective rate in the tamsulosin group was 78.2%,significantly higher than 25.1% in the control group.12 weeks after treatment ended,the score of CPSI in the tamsulosin group had a obvious decrease compared with that at the end of treatment,while without obvious change in the control group(compared with that before the treatment,the decrease in the score of CPS

文档评论(0)

docman126 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档